| Previous Close | 0.0680 |
| Open | 0.0000 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0000 - 0.0000 |
| 52 Week Range | |
| Volume | 0 |
| Avg. Volume | 94,171,156 |
| Market Cap | 41.97M |
| Beta | 0.46 |
| PE Ratio (TTM) | -0.28 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Benzinga•last month
10 Pieces Of Advice Every Penny Stock Trader Should Know
Trading penny stocks is one of the riskiest investments in today’s market. The stocks are extremely cheap for a reason, and this causes the stocks them be so volatile. With that being said, Benzinga talked ...
- Benzinga•2 months ago
We Spoke With The Experts, And Learned The Secrets Behind Beating The Penny Stock Market
With their inorganic moves and promotional gimmicks, learning how to properly trade penny stocks could be extremely valuable for everyday investors. Benzinga often receives reader inquiries on penny stocks. ...
- Investopedia•6 months ago
Delcath Clinical Study Design Approved By FDA
The FDA approved the design of Delcath's clinical trial for its Melphalan HDS chemo delivery product.
